Skip to main content

Table 3 Comparisons of SCE between the HPSD group and conventional group

From: Impact of high-power short-duration atrial fibrillation ablation technique on the incidence of silent cerebral embolism: a prospective randomized controlled study

Variables

HPSD group (n = 22)

Conventional group (n = 20)

P value

Patients with SCE (n, %)

22 (44%)

20 (40%)

0.685†

Average number of lesions (n, IQR)

2.0 (1.0–3.25)

2.0 (1.0–3.0)

0.751*

Maximum lesion diameter (mm, IQR)

4.96 (3.57–6.36)

4.14 (3.19–5.67)

0.406*

Classification of lesions

 Small lesions (diameter < 3 mm) (n, %)

26/55 (47.3%)

27/51 (52.9%)

0.637*

 Medium lesions (3 mm ≤ diameter < 10 mm) (n, %)

29/55 (52.7%)

23/51 (45.1%)

 Large lesions (diameter ≥ 10 mm) (n, %)

0

1/51 (2.0%)

Total lesion volume per patient (mm3, IQR)

46.8 (24.1–148.3)

43.3 (22.7–104.1)

0.669*

  1. HPSD high-power short-duration, IQR interquartile range, SCE silent cerebral embolism
  2. *Mann–Whitney U test
  3. †Chi-square test